English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
Researcher develops drug delivery system for chemo-induced hearing loss
Researcher develops drug delivery system for chemo-induced hearing loss
Five key factors predict the response of cancer patients to immunotherapy
Five key factors predict the response of cancer patients to immunotherapy
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
Risk of secondary cancers after CAR T therapy may be similar to risk after other cancer treatments
University develops novel bone cancer therapy which has 99% success rate
University develops novel bone cancer therapy which has 99% success rate
PARP1 selective inhibitor yields potent and durable antitumour activity in patient-derived preclinical models
PARP1 selective inhibitor yields potent and durable antitumour activity in patient-derived preclinical models
Old chemotherapy drug, new pancreatic cancer therapy?
Old chemotherapy drug, new pancreatic cancer therapy?
Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent prostate cancer
Precision drug olaparib may be effective without hormone therapy for some men with biochemically recurrent...
Tumour cell–coated carbon nanohorn tested for efficient delivery of drugs in cancer therapy
Tumour cell–coated carbon nanohorn tested for efficient delivery of drugs in cancer therapy
Small molecules, big impact: advancing immune checkpoint inhibitors for cancer
Small molecules, big impact: advancing immune checkpoint inhibitors for cancer
<1...910111213...370>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top